Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

About the menopausal depression.

Peter Gaszner1

  • 1National Institute of Psychiatry and Neurology, Budapest, Hungary.

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology
|February 25, 2006
PubMed
Summary

Menopausal depression treatment is most effective with a combination of antidepressants and psychotherapy. Individualized therapy plans are crucial for managing depression during menopause.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Complex therapy of schizophrenia].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology·2009
Same author

[Alarm in Hungarian psychiatry and clinical psychopharmacology].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology·2007
Same author

Comparison between genes of Alzheimer's disease and brain tissue of others.

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology·2007
Same author

Culturally-sensitive complaints of depressions and anxieties in women.

Journal of affective disorders·2006
Same author

[Clinical observations with aripiprazole in schizophrenia].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology·2006
Same author

[Pharmacovigilance as new direction of research].

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology·2006

Area of Science:

  • Reproductive endocrinology
  • Psychiatry
  • Clinical psychology

Background:

  • Menopause is associated with an increased risk of depression, linked to declining estrogen levels.
  • Other hormonal changes during perimenopause, such as progesterone and inhibin levels, may also contribute to depressive symptoms.
  • Central nervous system activity of gonadal steroids could play a role in menopausal depression.

Purpose of the Study:

  • To evaluate the efficacy of different treatment strategies for major depression in women aged 39-51.
  • To compare the effectiveness of fluoxetine, estrogen, and their combination with cognitive psychotherapy.

Main Methods:

  • An open-label clinical trial involving 40 patients diagnosed with major depression.
  • Participants were treated with fluoxetine, estrogen, a combination of fluoxetine and estrogen, or fluoxetine plus cognitive psychotherapy.
  • Treatment duration was six weeks, with outcomes assessed using the Clinical Global Impression Scale.

Main Results:

  • Estrogen monotherapy showed improvement in 4 out of 10 patients.
  • Fluoxetine alone or in combination with estrogen resulted in improvement for 6 out of 10 patients.
  • The combination of antidepressants and cognitive psychotherapy led to improvement in 8 out of 10 patients.

Conclusions:

  • Combination therapy with antidepressants and psychotherapy appears to be the most effective treatment for menopausal depression.
  • Treatment plans for menopausal depression should be individualized to optimize patient outcomes.

Related Experiment Videos